Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
27.66
-0.11 (-0.40%)
At close: Sep 11, 2026, 4:00 PM EDT
27.89
+0.23 (0.83%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Alamar Biosciences Revenue
Alamar Biosciences had revenue of $29.43M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $100.42M. In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth.
Revenue (ttm)
$100.42M
Revenue Growth
+195.17%
P/S Ratio
19.27
Revenue / Employee
$351,119
Employees
286
Market Cap
1.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ALMR News
- 12 days ago - Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Alamar Biosciences price target raised to $31 from $30 at BofA - TheFly
- 4 weeks ago - Alamar Biosciences price target raised to $32 from $28 at Stifel - TheFly
- 4 weeks ago - Alamar Biosciences price target raised to $35 from $32 at JPMorgan - TheFly
- 4 weeks ago - Alamar Biosciences expands Alzheimer’s Data Initiative deal with 86K samples - TheFly
- 4 weeks ago - Alamar Biosciences reports Q2 EPS (22c), consensus (32c) - TheFly
- 4 weeks ago - Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M - TheFly
- 4 weeks ago - Alamar Biosciences Earnings Call Transcript: Q2 2026 - Transcripts